Biography
Dr Michael Krasovitsky is a medical oncologist at St Vincent's Hospital Darlinghurst specialising in geriatric oncology, supportive care & toxicity management, liver malignancies, thyroid cancers, and cancers of unknown primary. He is the chair of the Geriatric Oncology multi-disciplinary service at St Vincent's. He holds an MBBS with honours from the Australian National University, and has also completed higher training in biostatistics and...view more
Dr Michael Krasovitsky is a medical oncologist at St Vincent's Hospital Darlinghurst specialising in geriatric oncology, supportive care & toxicity management, liver malignancies, thyroid cancers, and cancers of unknown primary. He is the chair of the Geriatric Oncology multi-disciplinary service at St Vincent's. He holds an MBBS with honours from the Australian National University, and has also completed higher training in biostatistics and epidemiology as part of a Masters of International Public Health (Distinction) through UNSW. Dr Krasovitsky is chair of the Geriatric Oncology Emerging Experts and Researchers group (GOEER), as well as a member of the COSA Geriatric Oncology executive. He is involved in a number of quality improvement initiatives locally and nationally, primarily focussing on end of life care, systemic therapy safety, and supportive care. He is also involved in a number of research endeavours, with his primary focus being on providing optimal cancer care to older individuals with cancer.
My Grants
Dr Krasovitsky has experience in submitting for MRFF and NH&MRC grants, and is currently listed as an investigator on a number of grants in the field of geriatric oncology.
My Qualifications
FRACP (Medical Oncology) (2021)
MBBS (Hons I) (Dux) (2013)
Masters of International Public Health (Distinction) (2022)
BA (Languages) (Honours) (2009)
Diploma of child health (2015)
My Research Activities
Dr Krasovitsky is primarily involved in research in the following fields:
1. Geriatric Oncology & optimal care pathways for older individuals with cancer.
2. Supportive care & toxicity management among patients with cancer.
3. Thyroid malignancies.
4. Hepatic malignancies.
5. Quality of life measurement and intervention amongst patients with cancer.